ELOX Eloxx Pharmaceuticals, Inc.

Fundamentals / CIK 0001035354 / USD

Eloxx Pharmaceuticals, Inc. reported $0 in revenue and a net loss of $15.84M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ELOX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2025), reported in USD.

$13.31M$6.66M$0-$62.93MFY 2017 Net Income: -$934K2017FY 2017 Net Income: -$21.21M2017FY 2018 Net Income: -$47.19M2018FY 2019 Net Income: -$50.87M2019FY 2020 Net Income: -$34.58M2020FY 2021 Net Income: -$66.73M2021FY 2022 Net Income: -$36.06M2022FY 2023 Revenue: $0FY 2023 Net Income: -$17.05M2023FY 2024 Revenue: $6.36MFY 2024 Net Income: -$3.14M2024FY 2025 Revenue: $0FY 2025 Net Income: -$6.00M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30
Revenue $0 $6.36M $0 -- -- -- -- -- -- --
Research & Development $3.06M $3.58M $8.60M $23.73M $22.90M $14.59M $26.35M $20.49M $16.40M $280K
Total Operating Expenses $6.44M $8.83M $17.29M $34.42M $66.02M $33.45M $50.55M $47.56M $20.39M --
Operating Income -$6.44M -$2.47M -$17.29M -$34.42M -$66.02M -$33.45M -$50.55M -$47.56M -$20.39M -$2.21M
EBITDA -$6.44M -$2.43M -$17.18M -$34.34M -$65.90M -$33.39M -$50.47M -$47.35M -$20.35M -$2.17M
Interest Expense -- -- -- -- -- -- -- -- $43K --
Income Before Tax -$6.00M -$3.14M -$17.05M -$36.06M -$66.73M -$34.58M -$50.87M -$47.06M -$21.21M -$1.57M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $122K -- -$640K
Net Income -$6.00M -$3.14M -$17.05M -$36.06M -$66.73M -$34.58M -$50.87M -$47.19M -$21.21M -$934K
Basic EPS -$0.49 -$0.84 -$6.63 -$666.00 -$1,526.00 -$34.40 -$53.60 -$58.00 -$190.00 -$2.00
Diluted EPS -$0.49 -$0.84 -$6.63 -$666.00 -$1,526.00 -$34.40 -$53.60 -$58.00 -$190.00 -$2.00
Basic Shares Outstanding 12.3M 3.8M 2.6M 54.2K 43.7K 1.0M 951.6K 810.9K 124.4K 512.4K
Diluted Shares Outstanding 12.3M 3.8M 2.6M 54.2K 43.7K 1.0M 951.6K 810.9K 124.4K 512.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2023-12-31
Research & Development $4.03M $2.84M $1.66M $1.90M -$250K $898K $510K $1.52M
Total Operating Expenses $5.95M $4.45M $3.79M $3.35M $285K $1.58M $1.22M $4.03M
Operating Income -$5.95M -$4.45M -$3.79M -$3.35M -$285K -$1.58M -$1.22M -$4.03M
EBITDA -- -- -- -- -- -- -- -$3.96M
Interest Expense $100K $100K $100K -- $200K $300K $500K --
Net Income -$5.54M -$4.50M -$3.75M -$2.04M -$351K -$1.89M -$1.71M -$2.89M
Basic EPS -$0.49 -$0.66 -$0.08 -- -$0.58 -$5.45 -$0.45 --
Diluted EPS -$0.49 -$0.66 -$0.08 -- -$0.58 -$5.45 -$0.45 --
Basic Shares Outstanding 11.4M 6.8M 48.2M -- 604.3K 347.0K 3.8M --
Diluted Shares Outstanding 11.4M 6.8M 48.2M -- 604.3K 347.0K 3.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30
Cash & Cash Equivalents $4.79M $111K $1.13M $19.21M $42.27M $24.67M $22.49M $48.61M $24.05M $13.36M
Short-Term Investments -- -- -- -- -- -- $33.78M -- -- --
Cash & Short-Term Investments $4.79M $111K $1.13M $19.21M $42.27M $24.67M $56.28M $48.61M $24.05M $13.36M
Total Current Assets $5.27M $2.98M $1.55M $20.13M $43.48M $25.89M $57.71M $50.34M $24.51M $284K
Property, Plant & Equipment, Net $0 $0 $35K $169K $216K $133K $201K $248K $278K $51K
Other Non-Current Assets -- -- -- -- -- $30K $113K $129K -- --
Total Non-Current Assets $0 $0 $164K $994K $1.66M $584K $1.24M $377K $278K $5.56M
Total Assets $5.27M $2.98M $1.71M $21.12M $45.14M $26.48M $58.95M $50.72M $24.78M $5.85M
Accounts Payable $2.71M $5.35M $5.70M $3.02M $1.38M $481K $1.87M $747K $1.53M $192K
Short-Term Debt $1.00M $6.52M $2.22M $3.98M $0 $5.24M $4.34M -- -- --
Other Current Liabilities -- -- -- -- -- -- -- -- -- $0
Total Current Liabilities $17.18M $27.31M $22.70M $23.09M $9.96M $9.84M $11.81M $7.81M $3.42M $2.77M
Long-Term Debt $0 $0 $1.61M $8.56M $12.00M $6.38M $10.50M -- -- --
Other Non-Current Liabilities -- -- -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $0 $0 $1.61M $8.69M $12.80M $6.41M $10.93M $0 $0 $2.20M
Total Liabilities $17.18M $27.31M $24.31M $31.78M $22.75M $16.25M $22.73M $7.81M $3.42M $4.97M
Total Debt (incl. Leases) $1.00M $6.52M $3.97M $13.38M $13.46M $12.04M $15.76M -- -- --
Common Stock $4.0K $35K $31K $22K $22K $404K $402K $360K $274K $292K
Retained Earnings -$300.6M -$294.6M -$291.4M -$274.4M -$238.3M -$171.6M -$137.0M -$86.14M -$38.96M -$121.8M
Accumulated Other Comp. Income -- -- -- -- -- -- $18K -- -- --
Total Stockholders' Equity -$11.91M -$24.34M -$22.60M -$10.66M $22.38M $10.23M $36.21M $42.91M $21.36M $871K
Total Equity -$11.91M -$24.34M -$22.60M -$10.66M $22.38M $10.23M $36.21M $42.91M $21.36M $871K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2024-12-31 2023-12-31 2023-09-30 2023-06-30
Cash & Cash Equivalents $56.26M $61.96M $6.36M $4.79M $111K $1.13M $4.78M $4.33M
Cash & Short-Term Investments $56.26M $61.96M $6.36M $4.79M $111K $1.13M $4.78M $4.33M
Total Current Assets $58.26M $63.39M $8.50M $5.27M $2.98M $1.55M $5.63M $5.38M
Property, Plant & Equipment, Net -- -- -- $0 $0 $35K $107K $130K
Total Non-Current Assets $0 $0 $0 $0 $0 $164K $413K $611K
Total Assets $58.26M $63.39M $8.50M $5.27M $2.98M $1.71M $6.04M $5.99M
Accounts Payable $2.42M $3.03M $3.03M $2.71M $5.35M $5.70M $3.13M $3.12M
Short-Term Debt $0 $0 $0 $1.00M $6.52M $2.22M $2.82M $2.28M
Total Current Liabilities $17.19M $16.97M $16.09M $17.18M $27.31M $22.70M $23.47M $21.25M
Long-Term Debt -- -- -- $0 $0 $1.61M $2.62M $3.33M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $1.61M $2.62M $3.34M
Total Liabilities $17.19M $16.97M $16.09M $17.18M $27.31M $24.31M $26.09M $24.59M
Total Debt (incl. Leases) $0 $0 $0 $1.00M $6.52M $3.97M $5.76M $6.11M
Common Stock $41K $40K $51K $4.0K $35K $31K $31K $25K
Retained Earnings -$314.4M -$308.8M -$304.3M -$300.6M -$294.6M -$291.4M -$288.6M -$285.0M
Total Stockholders' Equity $41.07M $46.42M -$7.58M -$11.91M -$24.34M -$22.60M -$20.05M -$18.60M
Total Equity $41.07M $46.42M -$7.58M -$11.91M -$24.34M -$22.60M -$20.05M -$18.60M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30
Net Income -$6.00M -$3.14M -$17.05M -$36.06M -$66.73M -$34.58M -$50.87M -$47.19M -$21.21M -$934K
Depreciation & Amortization $0 $35K $113K $77K $114K $68K $87K $216K $39K $44K
Stock-Based Compensation $235K $541K $1.97M $3.02M $9.17M $8.67M $11.34M $13.37M $101K $80K
Change in Receivables $359K -$359K $0 -- -- -- -- -- -- --
Change in Payables -$2.63M -$353K $2.68M $1.64M -$320K -$1.39M $1.12M -$780K -$583K $101K
Operating Cash Flow -$6.33M -$4.71M -$14.34M -$31.84M -$35.00M -$28.17M -$39.39M -$31.37M -$15.94M -$1.93M
Capital Expenditure -- -- -- -$66K -$89K -- -$40K -$235K -$237K -$2.5K
Free Cash Flow -- -- -- -$31.91M -$35.09M -- -$39.43M -$31.60M -$16.17M -$1.93M
Purchases of Investments -- -- -- -- -- -- -$67.21M -- -- --
Investing Cash Flow $1.0K $38K $309K -$66K $2.06M $33.79M -$33.52M -$317K -$114K $48K
Common Stock Issued $0 $0 $3.15M $0 $47.72M -- $710K $2.17M $17.01M $0
Dividends Paid -- -- -- -- -- -- $0 $0 $0 --
Financing Cash Flow $11.00M $3.44M -$4.08M $8.81M $50.79M -$3.44M $46.80M $56.18M $37.95M $1.10M
Net Change in Cash $4.67M -$1.24M -$18.11M -$23.10M $17.84M $2.19M -$26.11M $24.50M $21.90M -$778K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2023-12-31
Net Income -$5.54M -$4.50M -$3.75M -$2.04M -$351K -$1.89M -$1.71M -$2.89M
Depreciation & Amortization -- -- -- -- -- -- -- $73K
Stock-Based Compensation $190K $95K $46K $189K $10K $16K $20K $340K
Change in Payables $176K -$782K $315K -$683K -$1.48M -$336K -$139K $2.55M
Operating Cash Flow -$4.28M -$4.79M -$5.45M -$4.06M -$1.72M -$1.75M $1.20M -$2.01M
Investing Cash Flow -- -- -- -- -- -- -- $51K
Financing Cash Flow -$1.42M $60.39M $7.03M $4.64M $5.35M $1.88M -$865K -$1.68M
Net Change in Cash -$5.70M $55.60M $1.58M $575K $3.64M $122K $339K -$3.64M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30
Operating Margin -- -38.8% -- -- -- -- -- -- -- --
Net Profit Margin -- -49.4% -- -- -- -- -- -- -- --
Return on Equity (ROE) -- -- -- -- -298.1% -338.0% -140.5% -110.0% -99.3% -107.2%
Return on Assets (ROA) -113.8% -105.6% -996.1% -170.7% -147.8% -130.6% -86.3% -93.0% -85.6% -16.0%
Current Ratio 0.31x 0.11x 0.07x 0.87x 4.37x 2.63x 4.89x 6.45x 7.16x 0.10x
Quick Ratio 0.28x 0.00x 0.05x 0.83x 4.25x 2.51x 4.77x 6.23x 7.03x 4.82x
Debt to Equity -- -- -- -- 0.60x 1.18x 0.44x -- -- --
Revenue Growth (YoY) -100.0% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2023-12-31
Return on Equity (ROE) -38.6% -22.9% -- -- -- -- -- --
Return on Assets (ROA) -27.2% -16.8% -94.6% -113.8% -- -- -- -996.1%
Current Ratio 3.39x 3.74x 0.53x 0.31x -- -- -- 0.07x
Quick Ratio 3.27x 3.65x 0.40x 0.28x -- -- -- 0.05x
Debt to Equity 0.00x 0.00x -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -552.9% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001035354) · from June 30, 1999 Data through September 30, 2026 · synced Nov 21, 2026, 05:00 UTC · Open in terminal